Depakote Tablet, Extended Release
Product Images NDC 0074-7402

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 0074-7402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Is A Stable Co-ordination Compound Comprised Of Sodium Valproate And Valproic Acid In A 1:1 Molar Relationship And Formed During The Partial Neutralization Of Valproic Acid With 0.5 Equivalent Of Sodium Hydroxide. Chemically It Is Designated As Sodium Hydrogen Bis(2-propylpentanoate). Divalproex Sodium Has The Following Structure: (Depakote Er Spl 01)

FDA Label Image

Figure 1 (Depakote Er Spl 02)

FDA Label Image

Figure 2 (Depakote Er Spl 03)

The text appears to be a graph or chart showing the reduction in CPS rate for high dose and low dose DEPAKOTE. It is not possible to generate a useful description without further context or information.*

FDA Label Image

Figure 3 (Depakote Er Spl 04)

FDA Label Image

Ndc 0074-3826-13 100 Tablets Once-daily Dosing Depakote® Er Divalproex Sodium Extended-release Tablets 250 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Depakote Er Spl 05)

This appears to be a medication label for Depakote, containing 100 tablets with 250 mg of valproic acid each. The package insert provides prescribing information and instructions to dispense the medication in a light-resistant container and store it at a temperature between 15-30°C (59-86°F). The label also includes a National Drug Code (NDC) and a Global Trade Item Number (GTIN), as well as the manufacturer's information, AbbVie Inc. However, there are also some errors and non-English characters present in the text.*

FDA Label Image

Ndc 0074-7126-11 100 Tablets To Open Tear Back Along Perforation Dispense The Accompanying Medication Guide To Each Patient. Rx Only Once-daily Dosing Depakote® Er Divalproex Sodium Extended-release Tablets 500 mg Valproic Acid Activity Tamper-evident: Do Not Accept If Opened Or Seal Has Been Broken. This Package For Households Without Young Children (Depakote Er Spl 06)

This is a medication called DEPAKOTE® used to treat seizures, bipolar disorder, and migraine headaches. It comes in the form of extended-release tablets containing Divalproex Sodium, which is equivalent to 250 mg of Valproic Acid. The tablets should be stored in a tightly sealed, light-resistant container at a temperature of 25°C (77°F) and protected from moisture. Each bottle contains 100 tablets and should not be taken if the seal over the bottle opening is broken. For more information about proper usage, please refer to the package insert or consult with a healthcare provider.*

FDA Label Image

Ndc 0074-7126-13 100 Tablets Once-daily Dosing Depakote® Er Divalproex Sodium Extended-release Tablets 500 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Depakote Er Spl 07)

This text contains product names, and some non-alphabetic characters. It is not clear what this text refers to, so the description cannot be provided.*

FDA Label Image

Depakote Er Spl 08

This is a description for a medication called Depakote (divalproex sodium extended-release tablets). This medication comes in a sealed bottle and should not be used if the seal is broken. It should be stored within a specific temperature range of 15-30°C (59-86°F). Each tablet contains 500mg of Oivalproex sodium equivalent to 10Valproic acid. The manufacturer is AbbVie LTO in Barceloneta, and the prescribing information can be found in the package insert. The N product identification number is GTIN: 0300747126132.*

FDA Label Image

Depakote Er Spl 09

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.